Mariam Alatrach<br />Apr 1, 2020; 69:681-688<br />Pathophysiology
…. more: Diabetes Journals (ADA) (Quelle/Source)
Aktuelle Seite: Startseite / Diabetes / Evidence Against an Important Role of Plasma Insulin and Glucagon Concentrations in the Increase in EGP Caused by SGLT2 Inhibitors
